rapid bladder cancer test / for tumor markers / urine / immunoassay
UBC®

{{requestButtons}}

Characteristics

  • Applications:

    bladder cancer

  • Tested parameter:

    for tumor markers

  • Sample type:

    urine

  • Analysis mode:

    immunoassay

Description

UBC® is an immunoassay for both primary diagnosis and monitoring of bladder cancer. The test specifically measures soluble fragments of cytokeratin 8 and 18 in urine samples. . Elevated amounts of cytokeratin protein fragments are present in the urine of many individuals with bladder cancer, even at early stages of the disease.

UBC® is available in Rapid, ELISA and IRMA format.
UBC® Rapid is a powerful Doctors-office test (Point-of-Care), for both primary diagnosis and monitoring of bladder cancer. The test specifically measures soluble fragments of cytokeratin 8 and 18 in urine samples. It can easily be performed by a nurse or a technician with minimal training and the results are obtained within 10 minutes. Elevated amounts of cytokeratin protein fragments are present in the urine of many individuals with bladder cancer, even at early stages of the disease.
UBC® Rapid shall be used for quantitative determination in combination with the POC-reader, concile® Ω100.

– The only quantitative POC test platform for urine based detection of bladder cancer.
– Easy and rapid to perform – result within 10 minutes
– Works in haematuria